EP
ZYME icon

Essential Partners’s Zymeworks ZYME Stock Holding History

Essential Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$318 Hold
12
– – ﹤0.01% 2506
2026
Q2 		$314 Hold
12
– – ﹤0.01% 2559
2026
Q1 		$300 Hold
12
– – ﹤0.01% 2551
2025
Q4 		$316 Hold
12
– – ﹤0.01% 2329
2025
Q3 		$205 Sell
12
-2
-14% -$29 ﹤0.01% 2399
2025
Q2 		$176 Buy
+14
New +$167 ﹤0.01% 1976

Other funds holding ZYME

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
B
BetterWealth San Jose, California $591M AUM 14.77% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Mather Group
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Essential Partners's ZYME Position: Q3 2026 in Review

Essential Partners held its Zymeworks (ZYME) position steady in Q3 2026 at 12 shares worth $318. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

Essential Partners first reported a position in ZYME in Q2 2025 and has held it in 6 quarters since. 10 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • Essential Partners held 12 shares of Zymeworks worth $318 as of Q3 2026.
  • Essential Partners left its Zymeworks share count unchanged in Q3 2026.
  • Zymeworks made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2506 holding.
  • Essential Partners first reported a position in Zymeworks in Q2 2025 and has held it in 6 quarters since.
  • 10 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.